Australia markets closed

Boundless Bio, Inc. (BOLD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.59-0.51 (-5.60%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
Total revenue
0
0
0
0
Operating expenses
Research development
42,637
42,637
37,159
19,278
Selling general and administrative
12,159
12,159
9,310
6,023
Total operating expenses
54,796
54,796
46,469
25,301
Operating income or loss
-54,796
-54,796
-46,469
-25,301
Total other income/expenses net
80
80
-100
-5
Income before tax
-49,434
-49,434
-45,901
-25,210
Income from continuing operations
-49,434
-49,434
-45,901
-25,210
Net income
-49,434
-49,434
-45,901
-25,210
Net income available to common shareholders
-49,434
-49,434
-45,901
-25,210
Basic EPS
-3.53
-
-3.28
-1.80
Diluted EPS
-3.53
-
-3.28
-1.80
Basic average shares
13,990
-
13,990
13,990
Diluted average shares
13,990
-
13,990
13,990